Abstract
Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.
Original language | English (US) |
---|---|
Pages (from-to) | 829-836 |
Number of pages | 8 |
Journal | Drugs of Today |
Volume | 40 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2004 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)